Association of cardiovascular risk factors and myocardial fibrosis with early cardiac dysfunction in type 1 diabetes: The diabetes control and complications trial/ epidemiology of diabetes interventions and complications study

Diabetes Care

Volumn 40, Issue 3, 2017, Pages 405-411

  Armstrong, Anderson C ^a,b   Ambale Venkatesh, Bharath ^a   Turkbey, Evrim ^a,c   Donekal, Sirisha ^a   Chamera, Elzbieta ^a   Backlund, Jye Yu ^d   Cleary, Patricia ^d   Lachin, John ^d   Bluemke, David A ^c   Lima, João A C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSIDADE FEDERAL DO VALE DO SÃO FRANCISCO   (Brazil)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; EARLY CARDIAC DYSFUNCTION; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; SMOKING; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CICATRIX; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 1; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CICATRIX; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 85016194326     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1889     Document Type: Article

References (35)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-2038
2. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF. The diabetic cardiomyopathy. Acta Diabetol 2011;48:173-181
3. Karamitsos TD, Tsapas A, Arnold JR. Diabetic cardiomyopathy: A controversial entity. Eur Heart J 2008;29:564; author reply 565
4. Rijzewijk LJ, van derMeer RW, Lamb HJ, et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 2009;54:1524-1532
5. Fagan A, Asghar O, Pearce K, et al. Medalists with extreme duration of type 1 diabetes exhibit only mild diastolic dysfunction and myocardial fibrosis. Diabetes Care 2015;38:e5-e6
6. Jellis C, Wright J, Kennedy D, et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging 2011;4:693-702
7. Turkbey EB, Backlund JY, Genuth S, et al.;DCCT/EDIC Research Group. Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation 2011;124:1737-1746
8. Kwong RY, Sattar H, Wu H, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008;118:1011-1020
9. Castillo E, Osman NF, Rosen BD, et al. Quantitative assessment of regional myocardial function with MR-Tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with harmonic phase (HARP) MRI. J Cardiovasc Magn Reson 2005;7: 783-791
10. Karamitsos TD, Karvounis HI, Didangelos T, Parcharidis GE, Karamitsos DT. Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients: A tissue Doppler echocardiographic study. Diabetes Care 2008;31:325-327
11. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-545
12. Epidemiology of Diabetes Interventions and Complications (EDIC). Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-Term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111
13. Nathan DM, Bayless M, Cleary P, et al.; DCCT/EDIC Research Group. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Advances and contributions. Diabetes 2013;62: 3976-3986
14. Gai N, Turkbey EB, Nazarian S, et al. T1 mapping of the gadolinium-enhanced myocardium: Adjustment for factors affecting interpatient comparison. Magn Reson Med 2011;65:1407-1415
15. Donekal S, Ambale-Venkatesh B, Berkowitz S, et al. Inter-study reproducibility of cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson 2013;15:37
16. Choi EY, Rosen BD, Fernandes VR, et al. Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: The Multi-Ethnic Study of Atherosclerosis. Eur Heart J 2013;34:2354-2361
17. Ambale-Venkatesh B, Armstrong AC, Liu CY, et al. Diastolic function assessed from tagged MRI predicts heart failure and atrial fibrillation over an 8-year follow-up period: The Multi-Ethnic Study of Atherosclerosis. Eur Heart J Cardiovasc Imaging 2014;15:442-449
18. Armstrong AC, Jacobs DR Jr, Gidding SS, et al. Framingham score and LV mass predict events in young adults: CARDIA study. Int J Cardiol 2014;172:350-355
19. Kishi S, Armstrong AC, Gidding SS, et al. Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: The CARDIA study (Coronary Artery Risk Development in Young Adults). JACC Heart Fail 2014;2: 500-508
20. Armstrong AC, Liu K, Lewis CE, et al. Left atrial dimension and traditional cardiovascular risk factors predict 20-year clinical cardiovascular events in young healthy adults: The CARDIA study. Eur Heart J Cardiovasc Imaging 2014;15: 893-899
21. Armstrong AC, Gidding SS, Colangelo LA, et al. Association of early adult modifiable cardiovascular risk factors with left atrial size over a 20-year follow-up period: The CARDIA study. BMJ Open 2014;4:e004001
22. Gidding SS, Liu K, Colangelo LA, et al. Longitudinal determinants of left ventricular mass and geometry: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Imaging 2013;6:769-775
23. Vestberg D, Rosengren A, Olsson M, Gudbjörnsdottir S, Svensson AM, Lind M. Relationship between overweight and obesity with hospitalization for heart failure in 20, 985 patients with type 1 diabetes: A population-based study from the Swedish National Diabetes Registry. Diabetes Care 2013;36: 2857-2861
24. Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, et al. Cigarette smoking exposure and heart failure risk in older adults: The Health, Aging, and Body Composition Study. Am Heart J 2012;164: 236-242
25. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up. Diabetes Care 2016;39:686-693
26. Genuth SM, Backlund JY, Bayless M, et al.; DCCT/EDIC Research Group. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC. Diabetes 2013;62:3561-3569
27. LindM, Bounias I, OlssonM, Gudbjörnsdottir S, SvenssonAM, Rosengren A. Glycaemic control and incidence of heart failure in 20, 985 patients with type 1 diabetes: An observational study. Lancet 2011;378:140-146
28. Konduracka E, Cieslik G, Galicka-Latala D, et al. Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: A 7-year prospective cohort study. Acta Diabetol 2013;50:597-606
29. Nyström T, Holzmann MJ, Eliasson B, Kuhl J, Sartipy U. Glycemic control in type 1 diabetes and long-Term risk of cardiovascular events or death after coronary artery bypass grafting. J Am Coll Cardiol 2015;66:535-543
30. Dale AC, Midthjell K, Nilsen TI, Wiseth R, Vatten LJ. Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT study in Norway. Eur Heart J 2009;30:1372-1377
31. Seferovíc PM, Paulus WJ. Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes. Eur Heart J 2015;36:1718-1727, 1727a-1727c
32. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57:891-903
33. Garot J, Lima JA, Gerber BL, et al. Spatially resolved imaging of myocardial function with strain-encoded MR: comparison with delayed contrast-enhanced MR imaging after myocardial infarction. Radiology 2004;233:596-602
34. Liu CY, Liu YC, Wu C, et al. Evaluation of agerelated interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2013;62:1280-1287
35. Adameova A, Dhalla NS. Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev 2014;19:25-33